![]() Divide & Conquer Divide & Conquer is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumors with very poor life expectancy. | ![]() Arch Oncology Arch Oncology is a clinical-stage immuno-oncology company focused on the discovery and development of antibody therapies for the treatment of patients with cancer. | ![]() Paradigm Diagnostics Paradigm Diagnostics is a precision medicine company focused on comprehensive cancer testing. | ![]() HUYA Bioscience International HUYA Bioscience International is a company specializing in the biopharmaceutical products. | |
Founding Date | Founding Date 2018 | Founding Date 2006 | Founding Date 2012 | Founding Date 2004 |
Type | Type Private | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations Babraham, GB HQ | Locations Brisbane, US HQ St. Louis, US | Locations Phoenix, US HQ | Locations San Diego, US HQ Chengdu Shi, CN Guangzhou Shi, CN Hangzhou, CN Shenzhen Shi, CN Shenzhen Shi, CN Suzhou Shi, CN see more |
Employees | Employees 2 | Employees 7 | Employees 717% increase | Employees 1113% increase |
Funding | ||||
Latest funding round | Latest funding round $ 12.5m (over 6 years ago) | Latest funding round $ 105m (about 5 years ago) | Latest funding round $ 15m (almost 7 years ago) | Latest funding round $ 7.6m (about 14 years ago) |
Total funding raised | Total funding raised $ 12.5m | Total funding raised $ 155m | Total funding raised $ 23.9m | Total funding raised $ 12.6m |

Arch Oncology is a clinical-stage immuno-oncology company focused on the discovery and development of antibody therapies for the treatment of patients with cancer.
View company
Paradigm Diagnostics is a precision medicine company focused on comprehensive cancer testing.
View company
HUYA Bioscience International is a company specializing in the biopharmaceutical products.
View company